porcilis pcv
intervet international bv - porcine circovirus type 2 orf2 subunit antigen - immunologicals for suidae - pigs - for the active immunisation of pigs to reduce the virus load in blood and lymphoid tissues and to reduce weight loss associated with porcine-circovirus-type-2 infection occurring during the fattening period.onset of immunity: 2 weeksduration of immunity: 22 weeks
circovac
ceva-phylaxia oltóanyagtermelõ zrt. - inactivated porcine circovirus type 2 (pcv2) - immunologicals for suidae - pigs (gilts and sows) - sows and giltspassive immunisation of piglets via the colostrum, after active immunisation of sows and gilts, to reduce lesions in lymphoid tissues associated with pcv2 infection and as an aid to reduce pcv2-linked mortality.pigletsactive immunisation of piglets to reduce faecal excretion of pcv2 and virus load in blood, and as an aid to reduce pcv2-linked clinical signs, including wasting, weight loss and mortality, as well as to reduce virus load and lesions in lymphoid tissues associated with pcv2 infection.
suvaxyn pcv
zoetis belgium sa - porcine circovirus recombinant virus (cpcv) 1-2, inactivated - immunologicals - pigs (piglets) - active immunisation of pigs over the age of three weeks against porcine circovirus type 2 (pcv2) to reduce viral load in blood and lymphoid tissues, and the lesions in lymphoid tissues associated with pcv2 infection, as well as to reduce clinical signs - including loss of daily weight gain, and mortality associated with post-weaning multisystemic wasting syndrome.
porcine parvac vaccine
zoetis australia pty ltd - porcine parvo virus - inactivated; thiomersal - misc. vaccines or anti sera - porcine parvo virus - inactivated vaccine-viral active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - parvovirus
fostera pcv mh
zoetis australia pty ltd - mycoplasma hyopneumoniae - inactivated antigen; cpcv 1-2 inactivated suspension; thiomersal - misc. vaccines or anti sera - mycoplasma hyopneumoniae - inactivated antigen vaccine-general active 1.0 rp; cpcv 1-2 inactivated suspension vaccine-virus active 1.0 rp; thiomersal mercury other 0.1 mg/ml - immunotherapy
plevac parvovirus/leptospirosis/erysipelas vaccine for pigs
intervet australia pty limited - erysipelothrix rhusiopathiae; leptospira interrogans serovar pomona; porcine parvo virus; formaldehyde; thiomersal - parenteral liquid/solution/suspension - erysipelothrix rhusiopathiae vaccine-general active 0.0 u; leptospira interrogans serovar pomona vaccine-microbial active 0.0 u; porcine parvo virus vaccine-viral active 0.0 u; formaldehyde aldehyde other 0.3 mg/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - erysipelas - swine | leptospirosis - leptospira pomona | parvovirus | vaccine | equine rotavirus | l. interrogans serovar pomona | leptospira pomona infection | swine erysipelas
parvoruvax
merial animal health limited - inactivated porcine parovirus, k-22 strain, erysipelothrix rhusiopathiae (lysed bacterial cells), serotype 2 - suspension for injection - unknown - inactivated porcine parvovirus vaccine + inactivated erysipelothrix vaccine - porcine - immunological - inactivated vaccine
parvoruvax
merial animal health limited - inactivated porcine parovirus, k-22 strain, erysipelothrix rhusiopathiae (lysed bacterial cells), serotype 2 - suspension for injection - porcine parvovirus + erysipelothrix - porcine - immunological - inactivated vaccine
fostera pcv metastim
zoetis australia pty ltd - cpcv 1-2 inactivated suspension - misc. vaccines or anti sera - cpcv 1-2 inactivated suspension vaccine-virus active 1.0 rp - immunotherapy
parvoruvax
ceva santé animale - porcine parvovirus inactivated k-22 strain; erysipelothrix rhusiopathiae (lysed bacterial cells), serotype 2 - suspension for injection - . - porcine parvovirus + erysipelothrix - pigs - immunological - inactivated vaccine